2017-03-22,Zosano Announces Closing Of Public Offering Of Common Stock And Exercise Of Underwriters' Over-Allotment Option
2017-03-17,Zosano Announces Pricing Of Public Offering Of Common Stock
2017-03-01,Zosano Pharma Reports Fourth Quarter And Fiscal 2016 Financial Results And Business Update
2017-02-13,Fear of Missing Out Is Building
2017-02-13,Zosano Pharma Announces 3.8mg Dose Of M207, Its Novel Transdermal Therapeutic, Meets Both Co-primary Endpoints In The ZOTRIP Pivotal Efficacy Trial In Migraine
2017-01-31,Trading Action Has Improved, Here's What I Am Playing
2017-01-23,Zosano Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
2017-01-05,Zosano Pharma Announces Last Subject Treated In Its Migraine Pivotal Trial
2016-11-22,Zosano Pharma Announces Sale Of Non-Strategic Asset
2016-11-09,Zosano Pharma Reports Third Quarter 2016 Financial Results
2016-11-08,Zosano Pharma Announces Completion Of Enrollment In Pivotal Efficacy Trial For M207 For Acute Migraine
2016-09-09,Zosano Announces Inducement Grant For Georgia Erbez, Chief Business Officer
2016-09-08,Zosano Appoints Georgia Erbez As Chief Business Officer
2016-08-31,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Shareholders of Zosano Pharma Corporation - ZSAN
2016-08-26,ALERT: Rosen Law Firm Continues To Investigate Securities Claims Against Zosano Pharma Corporation
2016-08-16,Zosano Pharma Announces Pricing Of Private Placement Of Common Stock And Warrants
2016-08-10,Zosano Pharma Reports Second Quarter 2016 Financial Results
2016-07-25,First Subject Treated In Zosano Pharma's Pivotal Efficacy Trial For M207 Patch For Acute Migraine
2016-06-17,Zosano Pharma Enrolls First Subject In Pivotal Clinical Trial For ZP-Triptan Patch Program For Treatment Of Migraine
2016-05-17,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Zosano Pharma Corporation (ZSAN)
2016-05-12,INVESTOR ALERT: Investigation Of Zosano Pharma Corporation Announced By The Law Firm Goldman Scarlato & Penny, P.C.; Investors Encouraged To Contact The Firm
2016-05-12,Zosano Pharma Reports First Quarter 2016 Financial Results
2016-05-09,Zosano Announces Appointment Of John P. Walker As Chairman Of The Board
2016-05-02,Zosano Pharma To Report First Quarter 2016 Financial Results
2016-04-15,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Shareholders Of Zosano Pharma Corporation - ZSAN
2016-04-15,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Violations Of Federal Securities Laws By The Board Of Zosano Pharma Corporation -- ZSAN
2016-04-14,EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Zosano Pharma Corporation
2016-04-14,Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Zosano Pharma Corporation (ZSAN)
2016-04-08,ZOSANO NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Zosano Pharma Corporation To Contact The Firm
2016-04-08,IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of Claims Against Zosano Pharma Corporation And Advises Investors With Losses To Contact The Firm
2016-04-07,Scott + Scott, LLP Announces Investigation Of Zosano Pharma Corp (ZSAN), Encourages Investors With Losses To Contact Firm
2016-03-29,Zosano Pharma Reports Fourth Quarter And 2015 Financial Results And Business Update
2016-03-21,Zosano Pharma To Report Fourth Quarter And 2015 Financial Results and To Provide A Corporate Update
2016-03-09,Zosano Pharma To Present At The 28th Annual ROTH Conference
2016-03-01,Ratings Changes Today
2016-02-25,Lifshitz & Miller Law Firm Announces Investigation Of Ashford Hospitality Prime, Inc., Cobalt International Energy, Inc., Inovalon Holdings, Inc., Ooma, Inc., OvaScience, Inc., Swift Transportation Company, And Zosano Pharma Corporation
2016-02-09,INVESTOR ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Violations Of Federal Securities Laws By The Board Of Zosano Pharma Corporation -- ZSAN
2016-02-09,ZOSANO PHARMA SHAREHOLDER ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Continues Its Investigation Of Zosano Pharma Corporation; Encourages Investors To Contact The Firm For Information Concerning Their Legal Rights
2016-01-21,Harwood Feffer LLP Announces Investigation Of Zosano Pharma Corporation
2016-01-21,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Violations Of Federal Securities Laws By The Board Of Zosano Pharma Corporation
2016-01-20,Robbins Arroyo LLP Is Investigating The Officers And Directors Of Zosano Pharma Corporation (ZSAN) On Behalf Of Shareholders
2016-01-07,Zosano Pharma Announces Appointment Of Konstantinos Alataris, Ph.D. As President And Chief Executive Officer
2016-01-06,ZOSANO PHARMA SHAREHOLDER ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation Of Zosano Pharma Corporation; Encourages Investors To Contact The Firm For Information Concerning Their Legal Rights
2015-11-10,Zosano Pharma To Present At The Stifel 2015 Healthcare Conference
2015-11-09,Zosano Pharma Reports Third Quarter 2015 Financial Results
2015-11-03,Zosano Pharma To Announce Third Quarter 2015 Financial Results, Host Conference Call And Live Webcast On November 9, 2015
2015-11-02,Zosano Pharma Announces Positive Phase 1 Results For Its ZP-Triptan Patch Program For Treatment Of Migraine
2015-10-13,Zosano Pharma Announces Positive Phase 2 Results For Its ZP-Glucagon Patch Program For Treatment Of Severe Hypoglycemia
2015-09-28,Zosano Pharma Resumes Development Of Weekly ZP-PTH Treatment For Severe Osteoporosis
2015-09-23,Zosano Pharma To Present At The Ladenburg Thalmann 2015 Healthcare Conference
2015-09-08,Zosano Pharma Announces New Executive Appointment And Management Change
2015-09-01,Zosano Pharma Completes Enrollment In Phase 1 Study For Microneedle Patch Delivery Of Zolmitriptan For The Treatment Of Migraine
2015-08-12,Zosano Pharma Reports Second Quarter 2015 Financial Results
2015-07-13,Zosano Pharma Expands Clinical & Regulatory Teams With Three Strategic Hires
2015-07-06,Zosano Pharma Announces Discontinuation Of Novo Nordisk GLP-1 Patch Collaboration
2015-06-29,Zosano Pharma To Present At The Cantor Fitzgerald Inaugural Healthcare Conference
2015-06-29,Zosano Announces $15 Million Debt Financing
2015-06-23,Zosano Pharma Completes Enrollment In Phase 2 Trial For ZP-Glucagon, Its Microneedle Patch For Treatment Of Severe Hypoglycemia
2015-05-27,Zosano Pharma Appoints Joseph P. Hagan To Board Of Directors
2015-05-11,Zosano Pharma Reports First Quarter 2015 Financial Results
2015-04-30,Zosano Pharma Appoints New CMO, Fills Two New Operations Management Positions To Bolster Leadership Team
2015-03-25,Zosano Pharma Reports 2014 Financial Results
2015-03-03,Zosano Pharma To Present At The 27th Annual ROTH Conference
2015-01-27,Zosano Pharma Announces Pricing Of Initial Public Offering
,
,
,
